# Novartis (NVS) SEC filings: latest 20-F and 6-K reports

URL: https://funkfolio.com/stock/NVS/filings

> Novartis (NVS) SEC filings from EDGAR: 20-F filed Feb 4, 2026, 6-K filed Nov 12, 2026. 33 filings in the last 12 months, with insider and ownership forms.

---

## Novartis (NVS) SEC filings

Novartis's latest annual report is a Form 20-F filed on February 4, 2026 for the period ended December 31, 2025. Its latest Form 6-K report was filed on November 12, 2026. EDGAR lists 33 filings for it in the last twelve months.

### Key facts

- **Latest annual report:** 20-F, Feb 4, 2026
- **Latest 6-K:** 6-K, Nov 12, 2026
- **Filings, last 12 months:** 33
- **Insider forms, last 12 months:** 0 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 1
- **SEC central index key:** 0001114448

Filings as listed by SEC EDGAR at Nov 18, 2026, 11:28 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0001114448](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

Novartis: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm) | Feb 4, 2026 | Dec 31, 2025 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/nvs-20241231.htm) | Jan 31, 2025 | Dec 31, 2024 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000137036824000004/nvs-20231231.htm) | Jan 31, 2024 | Dec 31, 2023 | Annual report of a foreign private issuer |
| [20-F (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000137036823000048/nvs-20221231.htm) | May 15, 2023 | Dec 31, 2022 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000137036823000006/nvs-20221231.htm) | Feb 1, 2023 | Dec 31, 2022 | Annual report of a foreign private issuer |
| [20-F (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465922050394/tm2212193d1_20fa.htm) | Apr 26, 2022 | Dec 31, 2021 | FORM 20-F/A |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000137036822000010/nvs-20211231.htm) | Feb 2, 2022 | Dec 31, 2021 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000137036821000006/a21012620f.htm) | Jan 26, 2021 | Dec 31, 2020 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/a20012920f.htm) | Jan 29, 2020 | Dec 31, 2019 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/a19013020f.htm) | Jan 30, 2019 | Dec 31, 2018 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000104746918000380/a2234185z20-f.htm) | Jan 24, 2018 | Dec 31, 2017 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000104746917000338/a2230622z20-f.htm) | Jan 25, 2017 | Dec 31, 2016 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000104746916009872/a2227040z20-f.htm) | Jan 27, 2016 | Dec 31, 2015 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000104746915000433/a2222787z20-f.htm) | Jan 27, 2015 | Dec 31, 2014 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000104746914000415/a2217883z20-f.htm) | Jan 29, 2014 | Dec 31, 2013 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/1114448/000104746913000377/a2212460z20-f.htm) | Jan 23, 2013 | Dec 31, 2012 | Annual report of a foreign private issuer |

The latest 16 of 19 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

#### Reports of a foreign private issuer (Form 6-K)

Novartis: reports on Form 6-K

| Form | Filed | Report date | Document |
| --- | --- | --- | --- |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000110465926126289/tm2629242d6_6k.htm) | Nov 12, 2026 | Nov 12, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000111444826000014/a261027-6k.htm) | Oct 27, 2026 | Sep 30, 2026 | Report of a foreign private issuer |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184326005908/f6k_090826.htm) | Sep 8, 2026 | Sep 8, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184326005896/f6k_090426.htm) | Sep 4, 2026 | Sep 4, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184326005824/f6k_090126.htm) | Sep 1, 2026 | Sep 1, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000111444826000012/nvs-20260630.htm) | Jul 21, 2026 | Jun 30, 2026 | Report of a foreign private issuer |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184326004052/f6k_061126.htm) | Jun 11, 2026 | Jun 11, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000111444826000010/a260428-6k.htm) | Apr 28, 2026 | Mar 31, 2026 | Report of a foreign private issuer |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000110465926031037/tm268725d5_6k.htm) | Mar 18, 2026 | Mar 18, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000111444826000008/a260204rnfmar-6k.htm) | Feb 4, 2026 | Dec 31, 2025 | Report of a foreign private issuer |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000111444826000007/a260204-6k.htm) | Feb 4, 2026 | Dec 31, 2025 | Report of a foreign private issuer |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184325007547/f6k_112425.htm) | Nov 25, 2025 | Nov 24, 2025 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184325007445/f6k_112025.htm) | Nov 20, 2025 | Nov 20, 2025 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000110465925107058/tm2529850d5_6k.htm) | Nov 5, 2025 | Nov 5, 2025 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000111444825000003/a251028-6k.htm) | Oct 28, 2025 | Sep 30, 2025 | Report of a foreign private issuer |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184325006660/f6k_102625.htm) | Oct 27, 2025 | Oct 27, 2025 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184325006196/f6k_093025.htm) | Sep 30, 2025 | Sep 30, 2025 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184325005290/f6k_081125.htm) | Aug 11, 2025 | Aug 11, 2025 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000117184325004531/f6k_071725.htm) | Jul 17, 2025 | Jul 17, 2025 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/1114448/000137036825000012/nvs-20250630.htm) | Jul 17, 2025 | Jun 30, 2025 | Report of a foreign private issuer |

The latest 20 of 557 in EDGAR's recent list. A 6-K carries what the company publishes at home — results, press releases, notices to shareholders.

### Insider forms (3, 4 and 5)

Novartis: insider forms 3, 4 and 5 filed per month over the last twelve months

| Month | Forms filed |
| --- | --- |
| Nov 2026 | 0 |
| Oct 2026 | 0 |
| Sep 2026 | 0 |
| Aug 2026 | 0 |
| Jul 2026 | 0 |
| Jun 2026 | 0 |
| May 2026 | 0 |
| Apr 2026 | 0 |
| Mar 2026 | 0 |
| Feb 2026 | 0 |
| Jan 2026 | 0 |
| Dec 2025 | 0 |

Novartis: the latest insider forms

| Form | Filed | Transaction date |
| --- | --- | --- |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000110465925103023/xslF345X02/tm2529487-1_3seq1.xml) | Oct 28, 2025 | Oct 28, 2025 |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000110465922074790/xslF345X02/tm2219332-2_3seq1.xml) | Jun 27, 2022 | Jun 15, 2022 |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000110465920095585/xslF345X02/a3.xml) | Aug 14, 2020 | Aug 11, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000110465920084106/xslF345X03/a4.xml) | Jul 16, 2020 | Jul 14, 2020 |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000110465920082864/xslF345X02/a3.xml) | Jul 13, 2020 | Jul 9, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/xslF345X03/a4.xml) | Jul 2, 2020 | Jun 30, 2020 |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000110465920076964/xslF345X02/a3.xml) | Jun 25, 2020 | Jun 25, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/xslF345X03/edgar.xml) | Jun 22, 2020 | Jun 18, 2020 |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000089924320017188/xslF345X02/doc3.xml) | Jun 18, 2020 | Jun 18, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/xslF345X03/edgar.xml) | Jun 17, 2020 | Jun 15, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/xslF345X03/edgar.xml) | Jun 12, 2020 | Jun 10, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/xslF345X03/edgar.xml) | Jun 9, 2020 | Jun 5, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/xslF345X03/edgar.xml) | Jun 4, 2020 | Jun 2, 2020 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/xslF345X03/doc4.xml) | Nov 12, 2019 | Nov 12, 2019 |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000089924319026793/xslF345X02/doc3.xml) | Nov 6, 2019 | Nov 6, 2019 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/xslF345X03/a4.xml) | May 30, 2019 | May 28, 2019 |
| [3](https://www.sec.gov/Archives/edgar/data/1114448/000110465919031228/xslF345X02/a3.xml) | May 22, 2019 | May 22, 2019 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/xslF345X03/edgar.xml) | Apr 29, 2019 | Apr 25, 2019 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/xslF345X03/edgar.xml) | Apr 24, 2019 | Apr 22, 2019 |
| [4](https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/xslF345X03/edgar.xml) | Apr 15, 2019 | Apr 11, 2019 |

The latest 20 of 118 in EDGAR's recent list. Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

### Ownership reports (Schedules 13D and 13G)

Novartis: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000201238326003726/xslSCHEDULE_13G_X02/primary_doc.xml) | Oct 27, 2026 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1114448/000086117725000006/xslSCHEDULE_13G_X01/primary_doc.xml) | Jul 17, 2025 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924109522/tm2410988d42_sc13da.htm) | Oct 17, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924090137/tm2410988d41_sc13da.htm) | Aug 15, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924073960/tm2410988d28_sc13da.htm) | Jun 21, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924072306/tm2410988d26_sc13da.htm) | Jun 17, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924070037/tm2410988d25_sc13da.htm) | Jun 10, 2024 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924065615/tm2410988d23_sc13da.htm) | May 28, 2024 | — |
| [Schedule 13D](https://www.sec.gov/Archives/edgar/data/1114448/000110465924048774/tm2410988d11_sc13d.htm) | Apr 18, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000108636424006214/ch0012005267_020224.txt) | Feb 2, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000130655023006479/ch0012005267_020123.txt) | Feb 1, 2023 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1114448/000083423722007147/ch0012005267_020422.txt) | Feb 4, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465920096920/a20-28926_1sc13ga.htm) | Aug 19, 2020 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1114448/000119312518045654/d527041dsc13g.htm) | Feb 14, 2018 | — |
| [Schedule 13D](https://www.sec.gov/Archives/edgar/data/1114448/000110465918005861/a18-3997_2sc13d.htm) | Feb 1, 2018 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465917074069/a17-27581_1sc13ga.htm) | Dec 19, 2017 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465917070618/a17-27581_2sc13da.htm) | Nov 28, 2017 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1114448/000110465917055511/a17-21327_1sc13g.htm) | Sep 5, 2017 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465916142120/a16-17495_1sc13da.htm) | Aug 30, 2016 | — |
| [Schedule 13D (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465916138659/a16-16346_1sc13da.htm) | Aug 10, 2016 | — |

The latest 20 of 43 in EDGAR's recent list. Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

**Everything else (263 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

Novartis: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465926125262/tm2629242-3_424b5.htm) | Nov 10, 2026 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/1114448/000110465926124615/tm2629242d4_fwp.htm) | Nov 9, 2026 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465926124201/tm2629242-2_424b5.htm) | Nov 9, 2026 | — | Prospectus |
| [144](https://www.sec.gov/Archives/edgar/data/1114448/000195917326007516/xsl144X01/primary_doc.xml) | Oct 28, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1114448/000195917326003145/xsl144X01/primary_doc.xml) | Apr 30, 2026 | — | Notice of proposed sale |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465926029551/tm268725-2_424b5.htm) | Mar 17, 2026 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/1114448/000110465926028701/tm268725d3_fwp.htm) | Mar 17, 2026 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465926028048/tm268725-1_424b5.htm) | Mar 16, 2026 | — | Prospectus |
| [144](https://www.sec.gov/Archives/edgar/data/1114448/000195917326000921/xsl144X01/primary_doc.xml) | Feb 12, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1114448/000195917326000748/xsl144X01/primary_doc.xml) | Feb 9, 2026 | — | Notice of proposed sale |
| [S-8](https://www.sec.gov/Archives/edgar/data/1114448/000110465926010334/tm264157d1_s8.htm) | Feb 4, 2026 | — | FORM S-8 |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/1114448/000111444826000006/a260204IRAN.htm) | Feb 4, 2026 | — |  |
| [S-8 POS](https://www.sec.gov/Archives/edgar/data/1114448/000110465926004593/tm262520d4_s8pos.htm) | Jan 16, 2026 | — |  |
| [S-8 POS](https://www.sec.gov/Archives/edgar/data/1114448/000110465926004592/tm262520d3_s8pos.htm) | Jan 16, 2026 | — |  |
| [S-8 POS](https://www.sec.gov/Archives/edgar/data/1114448/000110465926004591/tm262520d2_s8pos.htm) | Jan 16, 2026 | — |  |
| [S-8 POS](https://www.sec.gov/Archives/edgar/data/1114448/000110465926004590/tm262520d1_s8pos.htm) | Jan 16, 2026 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/1114448/000110465926003727/tm263179d1_dfan14a.htm) | Jan 14, 2026 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/1114448/000110465926002891/tm262936d1_dfan14a.htm) | Jan 12, 2026 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465925106338/tm2529850-2_424b5.htm) | Nov 4, 2025 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/1114448/000110465925105776/tm2529850d3_fwp.htm) | Nov 4, 2025 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465925105278/tm2529850-1_424b5.htm) | Nov 3, 2025 | — | Prospectus |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/1114448/000110465925103267/tm2527010d12_dfan14a.htm) | Oct 28, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465925102943/tm2527010d11_sctota.htm) | Oct 28, 2025 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/1114448/000110465925102803/tm2529507d4_dfan14a.htm) | Oct 28, 2025 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/1114448/000110465925102646/tm2529507d3_dfan14a.htm) | Oct 27, 2025 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/1114448/000110465925102290/tm2529507d2_dfan14a.htm) | Oct 27, 2025 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/1114448/000110465925102268/tm2529507d1_dfan14a.htm) | Oct 27, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465925101411/tm2527010d10_sctota.htm) | Oct 22, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465925100641/tm2527010d9_sctota.htm) | Oct 20, 2025 | — |  |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/1114448/000110465925094086/tm2527010-1_sctot.htm) | Sep 29, 2025 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/1114448/000110465925088612/tm2525629d1_sctoc.htm) | Sep 9, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465925062424/tm2516065d12_sctota.htm) | Jun 25, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465925061301/tm2516065d11_sctota.htm) | Jun 23, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465925060052/tm2516065d10_sctota.htm) | Jun 17, 2025 | — |  |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/1114448/000110465925052701/tm2516065-1_sctot.htm) | May 27, 2025 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/1114448/000195917325003472/xsl144X01/primary_doc.xml) | May 23, 2025 | — | Notice of proposed sale |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/1114448/000110465925043563/tm2513674d2_sctoc.htm) | May 1, 2025 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/1114448/000110465925042639/tm2513674d1_sctoc.htm) | Apr 30, 2025 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/1114448/000195917325002749/xsl144X01/primary_doc.xml) | Apr 30, 2025 | — | Notice of proposed sale |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/1114448/000000000025003728/filename1.pdf) | Apr 8, 2025 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/1114448/000110465925029912/filename1.htm) | Mar 31, 2025 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/1114448/000000000025002918/filename1.pdf) | Mar 18, 2025 | — |  |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/1114448/000137036825000006/a250131iran.htm) | Jan 31, 2025 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465924100712/tm2423681-5_424b5.htm) | Sep 17, 2024 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/1114448/000110465924100277/tm2423681d6_fwp.htm) | Sep 16, 2024 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1114448/000110465924100040/tm2423681-4_424b5.htm) | Sep 16, 2024 | — | Prospectus |
| [F-3ASR](https://www.sec.gov/Archives/edgar/data/1114448/000110465924100011/tm2423681-2_f3asr.htm) | Sep 16, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924088996/tm2410988d40_sctot.htm) | Aug 13, 2024 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/1114448/000195917324005525/xsl144X01/primary_doc.xml) | Aug 12, 2024 | — | Notice of proposed sale |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924086787/tm2410988d39_sctota.htm) | Aug 7, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924085390/tm2410988d38_sctota.htm) | Aug 2, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924084926/tm2410988d37_sctota.htm) | Aug 1, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924084380/tm2410988d36_sctota.htm) | Jul 31, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924083987/tm2410988d35_sctota.htm) | Jul 30, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924083558/tm2410988d34_sctota.htm) | Jul 29, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924082651/tm2410988d33_sctota.htm) | Jul 25, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924080845/tm2410988d32_sctota.htm) | Jul 18, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/1114448/000110465924079238/tm2410988d31_sctota.htm) | Jul 11, 2024 | — |  |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/1114448/000110465924077888/tm2410988-29_sctot.htm) | Jul 5, 2024 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/1114448/000110465924073362/tm2410988d27_sctoc.htm) | Jun 20, 2024 | — |  |

The latest 60 of 263 in EDGAR's recent list.

### What the forms are

**Form 3 — Initial statement of beneficial ownership**

An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 5 — Annual statement of beneficial ownership**

An insider's annual statement of holdings in the company's equity securities.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Form 20-F — Annual report of a foreign private issuer**

Audited financial statements of the foreign private issuer and a discussion of its financial results; the same form is used to register a class of securities.

**Form 6-K — Report of a foreign private issuer**

Filed with press releases, communications to security holders, and disclosures the company's home country requires it to make to security holders.

**Schedule 13D — Schedule 13D beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities; also used to disclose later changes to the holding.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form 424B — Prospectus**

A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.

**Form SD — Specialized disclosure report**

In the SEC's Forms Index: Specialized Disclosure Report.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is Novartis's latest annual report (20-F)?**

Novartis filed its latest Form 20-F with the SEC on February 4, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**How many insider filings (Forms 3, 4 and 5) were there for NVS in the last year?**

0 insider forms in the twelve months to November 18, 2026, the latest a Form 3 filed on October 28, 2025. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of Novartis?**

EDGAR lists 1 Schedule 13D or 13G filing about Novartis in the last twelve months, the latest on October 27, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Novartis (NVS) SEC filings: latest 20-F and 6-K reports”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
